Insomnia News and Research

Latest Insomnia News and Research

Daytime sleepiness found to be a potential risk factor for Alzheimer’s disease

Older adults who frequently report feeling sleepy during the day are three times more likely to develop Alzheimer's in later life, according to a new study.

7 Sep 2018

Urological problems in men linked to depression and sleep disorders

Men who suffer from urological problems such as erectile dysfunction, urinary tract and bladder problems or infertility issues often also suffer from depression and sleep disorders.

31 Aug 2018

Pain, depression, and insomnia increase health care use in osteoarthritis patients

Pain was the main driver of seeking medical care in an Arthritis Care & Research study of patients with osteoarthritis. In addition to pain, insomnia and depression increased health care use.

22 Aug 2018

Seven activities that prevent you from getting quality sleep during summer

Summer is the season of barbeque, beach trips, and some of the simplest joys of life, but if you're not careful, it can also be the lone enemy of one of the most important joys of them all: sleep.

15 Aug 2018

Researchers discover new approach to alleviate chronic itch

Two receptors in the spinal cord and the right experimental drug: Researchers at the University of Zurich have discovered a new approach that suppresses itch.

14 Aug 2018

CNDA approves KEYTRUDA for treatment of advanced melanoma

Merck, known as MSD outside the United States and Canada, today announced that KEYTRUDA, Merck's anti-PD-1 therapy, has been approved by the China National Drug Administration for the treatment of adult patients with unresectable or metastatic melanoma following failure of one prior line of therapy.

26 Jul 2018

Researchers identify neural link between depression and sleep problems

The neural link between depression and sleep problems has been identified for the first time in a new study by researchers at the University of Warwick and Fudan University.

25 Jul 2018

Pivotal study of dasotraline in adults with binge eating disorder meets primary endpoint

Sunovion Pharmaceuticals Inc. today announced that a study evaluating the efficacy and safety of dasotraline in adults with moderate to severe binge eating disorder met its primary endpoint, demonstrating a statistically significant decrease in number of binge days per week from baseline to Week 12 in the group treated with dasotraline 6 mg/day versus the placebo-treated group.

25 Jul 2018

Phase 3 study of KEYTRUDA monotherapy meets primary endpoint

Merck, known as MSD outside the United States and Canada, announced today that the pivotal Phase 3 KEYNOTE-048 trial investigating KEYTRUDA, Merck's anti-PD-1 therapy, for first-line treatment of recurrent or metastatic head and neck squamous cell carcinoma, met a primary endpoint of overall survival as monotherapy in patients whose tumors expressed PD-L1.

25 Jul 2018

Sleep disturbances associated with higher dementia risk

Researchers at Karolinska Institutet in Sweden report that sleep disturbances in midlife or in late life are associated with a higher risk for developing dementia in old age. The results are published in Alzheimer's & Dementia: The Journal of the Alzheimer's Association.

20 Jul 2018

Nitrate-cured meats may contribute to mania, study finds

An analysis of more than 1,000 people with and without psychiatric disorders has shown that nitrates-chemicals used to cure meats such as beef jerky, salami, hot dogs and other processed meat snacks-may contribute to mania, an abnormal mood state. Mania is characterized by hyperactivity, euphoria and insomnia.

18 Jul 2018

FAU and partners receive NIH research grant to shed light on sleep loss and metabolic disorders

A neuroscientist from Florida Atlantic University's Jupiter Life Science Initiative and collaborators from the University of Minnesota and Stowers Institute for Medical Research recently a received a four-year, $1.68 million R01 research grant from the National Institutes of Health's National Institute of General Medical Sciences for a project titled, "Understanding Complex Trait Architecture through Population Genomics."

17 Jul 2018

New AASM guideline recommends use of actigraphy for sleep disorders

Actigraphy can be a useful clinical tool for the evaluation of adult and pediatric patients with suspected sleep disorders, including circadian rhythm sleep-wake disorders, according to a clinical practice guideline from the American Academy of Sleep Medicine

17 Jul 2018

Mindfulness-based approach could improve treatment for people with tinnitus

New UK research has found that a new mindfulness-based approach to tinnitus could transform the treatment of the condition.

2 Jul 2018

UT Southwestern study reveals structural information for major brain receptor

UT Southwestern researchers today published the first atomic structure of a brain receptor bound to a drug used to reverse anesthesia and to treat sedative overdoses.

28 Jun 2018

Even mild sleep disturbances can increase blood pressure in women

It is well known that chronic sleep deprivation can affect cardiovascular health. But according to a new study from Columbia University Irving Medical Center, even mild sleep problems, such as having trouble falling asleep, can raise blood pressure in women.

27 Jun 2018

Poor sleep quality may be important risk factor for atrial fibrillation

Poor sleep quality appears to be an important risk factor for atrial fibrillation, report scientists in the first study of its kind to demonstrate a relationship between poor sleep quality independent of sleep apnea and a higher risk of atrial fibrillation (AF).

26 Jun 2018

FDA approves new marijuana-based drug to treat rare and severe forms of epilepsy

The U.S. Food and Drug Administration today approved Epidiolex (cannabidiol) oral solution for the treatment of seizures associated with two rare and severe forms of epilepsy, Lennox-Gastaut syndrome and Dravet syndrome, in patients two years of age and older.

25 Jun 2018

Merck announces FDA acceptance of supplemental Biologics License Application for KEYTRUDA

Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has accepted for standard review a new supplemental Biologics License Application for KEYTRUDA, Merck's anti-PD-1 therapy, as adjuvant therapy in the treatment of patients with resected, high-risk stage III melanoma and granted a Prescription Drug User Fee Act, or target action, date of February 16, 2019.

25 Jun 2018

Researchers work to identify areas of the brain that help us wake up

Philosophers have pondered the nature of consciousness for thousands of years. In the 21st century, the debate over how the brain gives rise to our everyday experience continues to puzzle scientists.

22 Jun 2018

Insomnia News and Research

Latest Insomnia News and Research

Daytime sleepiness found to be a potential risk factor for Alzheimer’s disease

Urological problems in men linked to depression and sleep disorders

Pain, depression, and insomnia increase health care use in osteoarthritis patients

Seven activities that prevent you from getting quality sleep during summer

Researchers discover new approach to alleviate chronic itch

CNDA approves KEYTRUDA for treatment of advanced melanoma

Researchers identify neural link between depression and sleep problems

Pivotal study of dasotraline in adults with binge eating disorder meets primary endpoint

Phase 3 study of KEYTRUDA monotherapy meets primary endpoint

Sleep disturbances associated with higher dementia risk

Nitrate-cured meats may contribute to mania, study finds

FAU and partners receive NIH research grant to shed light on sleep loss and metabolic disorders

New AASM guideline recommends use of actigraphy for sleep disorders

Mindfulness-based approach could improve treatment for people with tinnitus

UT Southwestern study reveals structural information for major brain receptor

Even mild sleep disturbances can increase blood pressure in women

Poor sleep quality may be important risk factor for atrial fibrillation

FDA approves new marijuana-based drug to treat rare and severe forms of epilepsy

Merck announces FDA acceptance of supplemental Biologics License Application for KEYTRUDA

Researchers work to identify areas of the brain that help us wake up

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Insomnia News and Research

Latest Insomnia News and Research

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Newsletters you may be interested in